ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and advanced renal cell carcinoma
Cet article présente la mise à jour des recommandations de l'"European Society for Medical Oncology" concernant l'utilisation de l'immunothérapie pour traiter un carcinome à cellules rénales de stade précoce ou avancé
This special article provides key recommendations on the immunotherapy treatments of renal cell carcinoma.
Recommendations are based on available scientific data and the authors’ collective expert opinion.
Authorship includes a multidisciplinary group of experts from the ESMO renal cancer group.
Annals of Oncology , article en libre accès, 2021